Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P28472: Variant p.Tyr182Phe

Gamma-aminobutyric acid receptor subunit beta-3
Gene: GABRB3
Feedback?
Variant information Variant position: help 182 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Tyrosine (Y) to Phenylalanine (F) at position 182 (Y182F, p.Tyr182Phe). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are large size and aromatic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In DEE43. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 182 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 473 The length of the canonical sequence.
Location on the sequence: help MMDLRRYPLDEQNCTLEIES Y GYTTDDIEFYWRGGDKAVTG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         MMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGGDKAVTG

Mouse                         MMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGGDKAVTG

Rat                           MMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGGDKAVTG

Chicken                       MMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGGDNAVTG

Drosophila                    MMDLHYYPLDSQNCTVEIESYGYTVSDVVMYWK--PTPVRG
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 26 – 473 Gamma-aminobutyric acid receptor subunit beta-3
Topological domain 26 – 246 Extracellular
Binding site 180 – 182
Binding site 180 – 180 in chain A
Binding site 181 – 182 in chain B
Binding site 182 – 182 in chain A
Glycosylation 174 – 174 N-linked (GlcNAc...) asparagine
Beta strand 172 – 183



Literature citations
De novo mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies.
Epi4K Consortium;
Am. J. Hum. Genet. 99:287-298(2016)
Cited for: INVOLVEMENT IN DEE43; VARIANTS DEE43 ASN-120; MET-157; PHE-182; LYS-249; GLN-256; HIS-293 AND THR-305;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.